Vimarsana
Biggest News Aggregation in the World

Page 2 - Stem Cell Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stem Cell Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stem Cell Center Today - Breaking & Trending Today

Researchers Discover Disease-Causing Stem Cells in Lungs of Cystic Fibrosis Patients - Vimarsana News

Researchers Discover Disease-Causing Stem Cells in Lungs of Cystic Fibrosis Patients

Cells May Contribute to Lung Inflammation and Drug Resistance

Source: uh.edu
Researchers identify a major stem cell variant in lungs of patients with idiopathic pulmonary fibrosis - Vimarsana News

Researchers identify a major stem cell variant in lungs of patients with idiopathic pulmonary fibrosis

A pair of internationally renowned stem cell cloning experts at the University of Houston is reporting their findings of variant cells in the lungs of patients with Idiopathic Pulmonary Fibrosis (IPF) which likely represent key targets in any future therapy for the condition.

School of Medicine researchers and parent advocates collaborate for Angelman Syndrome patients - Vimarsana News

School of Medicine researchers and parent advocates collaborate for Angelman Syndrome patients

On March 31, members from the School of Medicine and the Foundation for Angelman Syndrome Therapeutics convened to reflect on progress being made towards combating the neurodegenerative disease.

Prof. Sendurai Mani joins the Datar Cancer Genetics Scientific Advisory Board - Vimarsana News

Prof. Sendurai Mani joins the Datar Cancer Genetics Scientific Advisory Board

Datar Cancer Genetics, a world leader in non-invasive cancer screening and diagnostics, today announced that Dr. Sendurai Mani, Ph.D has joined their Scientific

University of Houston: Stem Cell Cloning Experts Unraveling Cystic Fibrosis - Vimarsana News

University of Houston: Stem Cell Cloning Experts Unraveling Cystic Fibrosis

Two nationally recognized experts in cloning and stem cell science from the University of Houston are taking the first step toward limiting the consequences of chronic inflammation in cystic fibrosis (CF) by identifying the source of this persistent